Sample | Title | Value | Rank |
GSM1116933 | Synovial tissue prior to Tocilizumab therapy, repl 1 | -0.363083 | 6 |
GSM1116935 | Synovial tissue prior to Tocilizumab therapy, repl 2 | -1.15908 | 1 |
GSM1116937 | Synovial tissue prior to Tocilizumab therapy, repl 3 | 0.263885 | 89 |
GSM1116939 | Synovial tissue prior to Tocilizumab therapy, repl 4 | 0.516956 | 98 |
GSM1116941 | Synovial tissue prior to Tocilizumab therapy, repl 5 | 0.0740232 | 67 |
GSM1116943 | Synovial tissue prior to Tocilizumab therapy, repl 6 | 0.244312 | 87 |
GSM1116945 | Synovial tissue prior to Tocilizumab therapy, repl 7 | -1.18046 | 1 |
GSM1116947 | Synovial tissue prior to Tocilizumab therapy, repl 8 | -0.02005 | 48 |
GSM1116949 | Synovial tissue prior to Tocilizumab therapy, repl 9 | 1.03736 | 99 |
GSM1116951 | Synovial tissue prior to Tocilizumab therapy, repl 10 | -0.668715 | 1 |
GSM1116953 | Synovial tissue prior to Tocilizumab therapy, repl 11 | -1.2879 | 1 |
GSM1116955 | Synovial tissue prior to Tocilizumab therapy, repl 12 | -1.42 | 1 |
GSM1116934 | Synovial tissue after to Tocilizumab therapy, repl 1 | 3.83336 | 99 |
GSM1116936 | Synovial tissue after to Tocilizumab therapy, repl 2 | 1.15852 | 99 |
GSM1116938 | Synovial tissue after to Tocilizumab therapy, repl 3 | 0.274986 | 93 |
GSM1116940 | Synovial tissue after to Tocilizumab therapy, repl 4 | 1.09899 | 99 |
GSM1116942 | Synovial tissue after to Tocilizumab therapy, repl 5 | 0.51498 | 96 |
GSM1116944 | Synovial tissue after to Tocilizumab therapy, repl 6 | -0.693937 | 1 |
GSM1116946 | Synovial tissue after to Tocilizumab therapy, repl 7 | -0.53494 | 4 |
GSM1116948 | Synovial tissue after to Tocilizumab therapy, repl 8 | 1.36844 | 99 |
GSM1116950 | Synovial tissue after to Tocilizumab therapy, repl 9 | 0.995299 | 99 |
GSM1116952 | Synovial tissue after to Tocilizumab therapy, repl 10 | 0.0155764 | 55 |
GSM1116954 | Synovial tissue after to Tocilizumab therapy, repl 11 | -0.271681 | 7 |
GSM1116956 | Synovial tissue after to Tocilizumab therapy, repl 12 | -0.450309 | 3 |